Cargando…

Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke

Treatment for ischemic stroke can be offered beyond conventional time limits for patients with favorable computed tomography perfusion (CTP), but this is not universally available. We sought a threshold for brain attenuation on nonenhanced computed tomography (NECT) to differentiate CTP-defined penu...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzahrani, Awad, Zhang, Xinyu, Albukhari, Adel, Wardlaw, Joanna M., Mair, Grant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855746/
https://www.ncbi.nlm.nih.gov/pubmed/36601950
http://dx.doi.org/10.1161/STROKEAHA.122.041241
_version_ 1784873451124686848
author Alzahrani, Awad
Zhang, Xinyu
Albukhari, Adel
Wardlaw, Joanna M.
Mair, Grant
author_facet Alzahrani, Awad
Zhang, Xinyu
Albukhari, Adel
Wardlaw, Joanna M.
Mair, Grant
author_sort Alzahrani, Awad
collection PubMed
description Treatment for ischemic stroke can be offered beyond conventional time limits for patients with favorable computed tomography perfusion (CTP), but this is not universally available. We sought a threshold for brain attenuation on nonenhanced computed tomography (NECT) to differentiate CTP-defined penumbra vs core, and correlated NECT features with CTP. METHODS: We retrospectively assessed consecutive patients presenting to King Abdulaziz University Hospital with ischemic stroke (2017–2020), baseline NECT, and a visible defect on concurrent CTP. Using CTP as the reference standard, we measured the attenuation of ischemic and healthy contralateral brain on NECT to produce attenuation ratios (ischemic/normal) for penumbra and core. We used area under the receiver operating characteristic curve to estimate the optimal computed tomography (CT) attenuation ratio for penumbra. Per patient, we qualitatively assessed 8 regions within the affected cerebral hemisphere: on NECT as normal, hypoattenuating (with/out swelling), or isolated swelling and on CTP as normal, penumbra, or core. We sought associations between isolated swelling and penumbra, and between hypoattenuation and core. RESULTS: We include 142 patients (86 male), mean age 61±14 years. Median 261 minutes (interquartile range, 173–382) to NECT. We measured 206 ischemic lesions (124 penumbra, 82 core). Optimal CT attenuation ratio for identifying penumbra was >0.87, with 86% sensitivity 91% specificity (area under the receiver operating characteristic curve, 0.95 [95% CI, 0.92–0.98]; P<0.0001). We qualitatively assessed 976 cerebral regions (72 isolated swelling, 254 hypoattenuation). On NECT, isolated swelling usually corresponded to CTP penumbra (70/72, 97%), whereas visible NECT hypoattenuation was found with core (141/254, 56%) and penumbra (109/254, 43%). CTP core lesions were rarely normal on NECT (13/155, 8%). CONCLUSIONS: After ischemic stroke, brain tissue viability can be assessed using NECT. Isolated swelling is highly specific to penumbra. Visible hypoattenuation does not always represent core, nearly half of such lesions were penumbral on concurrent CTP and can be differentiated by measuring lesion attenuation.
format Online
Article
Text
id pubmed-9855746
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-98557462023-01-27 Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke Alzahrani, Awad Zhang, Xinyu Albukhari, Adel Wardlaw, Joanna M. Mair, Grant Stroke Original Contributions Treatment for ischemic stroke can be offered beyond conventional time limits for patients with favorable computed tomography perfusion (CTP), but this is not universally available. We sought a threshold for brain attenuation on nonenhanced computed tomography (NECT) to differentiate CTP-defined penumbra vs core, and correlated NECT features with CTP. METHODS: We retrospectively assessed consecutive patients presenting to King Abdulaziz University Hospital with ischemic stroke (2017–2020), baseline NECT, and a visible defect on concurrent CTP. Using CTP as the reference standard, we measured the attenuation of ischemic and healthy contralateral brain on NECT to produce attenuation ratios (ischemic/normal) for penumbra and core. We used area under the receiver operating characteristic curve to estimate the optimal computed tomography (CT) attenuation ratio for penumbra. Per patient, we qualitatively assessed 8 regions within the affected cerebral hemisphere: on NECT as normal, hypoattenuating (with/out swelling), or isolated swelling and on CTP as normal, penumbra, or core. We sought associations between isolated swelling and penumbra, and between hypoattenuation and core. RESULTS: We include 142 patients (86 male), mean age 61±14 years. Median 261 minutes (interquartile range, 173–382) to NECT. We measured 206 ischemic lesions (124 penumbra, 82 core). Optimal CT attenuation ratio for identifying penumbra was >0.87, with 86% sensitivity 91% specificity (area under the receiver operating characteristic curve, 0.95 [95% CI, 0.92–0.98]; P<0.0001). We qualitatively assessed 976 cerebral regions (72 isolated swelling, 254 hypoattenuation). On NECT, isolated swelling usually corresponded to CTP penumbra (70/72, 97%), whereas visible NECT hypoattenuation was found with core (141/254, 56%) and penumbra (109/254, 43%). CTP core lesions were rarely normal on NECT (13/155, 8%). CONCLUSIONS: After ischemic stroke, brain tissue viability can be assessed using NECT. Isolated swelling is highly specific to penumbra. Visible hypoattenuation does not always represent core, nearly half of such lesions were penumbral on concurrent CTP and can be differentiated by measuring lesion attenuation. Lippincott Williams & Wilkins 2023-01-05 2023-02 /pmc/articles/PMC9855746/ /pubmed/36601950 http://dx.doi.org/10.1161/STROKEAHA.122.041241 Text en © 2023 The Authors. https://creativecommons.org/licenses/by/4.0/Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
spellingShingle Original Contributions
Alzahrani, Awad
Zhang, Xinyu
Albukhari, Adel
Wardlaw, Joanna M.
Mair, Grant
Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke
title Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke
title_full Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke
title_fullStr Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke
title_full_unstemmed Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke
title_short Assessing Brain Tissue Viability on Nonenhanced Computed Tomography After Ischemic Stroke
title_sort assessing brain tissue viability on nonenhanced computed tomography after ischemic stroke
topic Original Contributions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855746/
https://www.ncbi.nlm.nih.gov/pubmed/36601950
http://dx.doi.org/10.1161/STROKEAHA.122.041241
work_keys_str_mv AT alzahraniawad assessingbraintissueviabilityonnonenhancedcomputedtomographyafterischemicstroke
AT zhangxinyu assessingbraintissueviabilityonnonenhancedcomputedtomographyafterischemicstroke
AT albukhariadel assessingbraintissueviabilityonnonenhancedcomputedtomographyafterischemicstroke
AT wardlawjoannam assessingbraintissueviabilityonnonenhancedcomputedtomographyafterischemicstroke
AT mairgrant assessingbraintissueviabilityonnonenhancedcomputedtomographyafterischemicstroke